Investigation on physicochemical and biological differences of cefpodoxime proxetil enantiomers

被引:10
|
作者
Kakumanu, Vasu Kumar
Arora, Vinod
Bansal, Arvind K.
机构
[1] NIPER, Dept Pharmaceut Technol Formulat, Punjab 160062, India
[2] Ranbaxy Res Labs, Gurgaon, Haryana, India
关键词
cefpodoxime proxetil; enantiomers; differences; enzymes; segments; regional metabolism; GIT; physicochemical; biological;
D O I
10.1016/j.ejpb.2006.05.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cefpodoxime proxetil (CP) is a prodrug of cefpodoxime acid (CA), and is supplied as racemic mixture of R- and S-enantiomers. CP has only 50% absolute bioavailability, and the reasons responsible for low bioavailability remain poorly understood. The present work ascertains physicochemical and biological properties of individual isomers of CP and explores their capacity to optimize delivery of CP. Both isomers showed similar pH stability behavior, but R-isomer was more susceptible to enzymatic metabolism compared to S-isomer, when incubated with enzymes collected from various segments of GIT. Based on the in vitro and in vivo results, use of S-isomer for development of a dosage form such as gastro-retentive dosage form can improve oral bioavailability of CP. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 50 条
  • [41] Characterization of impurities in cefpodoxime proxetil using LC MSn
    Li, Jin
    Zhang, Dousheng
    Hu, Changqin
    ACTA PHARMACEUTICA SINICA B, 2014, 4 (04) : 322 - 332
  • [42] Formulation and Evaluation of Sintered Floating Tablets of Cefpodoxime Proxetil
    Kukati, Latha
    Chittimalli, Kishore
    Shaik, Naseeb Basha
    Thoudoju, Shailaja
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 15 (03) : 278 - 290
  • [43] Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children
    Bairamis, TN
    Nikolopoulos, TP
    Kafetzis, DA
    Begue, P
    Lenfant, B
    Kandiloros, DC
    Apostolopoulos, NJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) : 821 - 824
  • [44] Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine
    Kees, F
    Wellenhofer, M
    Brohl, K
    Grobecker, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (04): : 435 - 438
  • [45] PHARMACOKINETICS AND INFLAMMATORY FLUID PENETRATION OF CEFPODOXIME PROXETIL IN VOLUNTEERS
    ONEILL, P
    NYE, K
    DOUCE, G
    ANDREWS, J
    WISE, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 232 - 234
  • [46] ANTIBACTERIAL ACTIVITY OF CEFPODOXIME PROXETIL IN A PHARMACOKINETIC INVITRO MODEL
    WIEDEMANN, B
    JANSEN, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (01) : 71 - 79
  • [47] DESIGN AND EVALUATION OF BILAYERED MUCOADHESIVE FILM OF CEFPODOXIME PROXETIL
    Banerjee, N.
    Singh, S. R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (04): : 1295 - 1302
  • [48] DEVELOPMENT AND EVALUATION OF A READY TO USE CEFPODOXIME PROXETIL SUSPENSION
    Kathpalia, H.
    Mittal, S.
    Bhatia, V.
    Pillai, P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (08): : 2173 - 2177
  • [49] TREATMENT OF ACUTE MAXILLARY SINUSITIS - COMPARING CEFPODOXIME PROXETIL WITH AMOXICILLIN
    VONSYDOW, C
    SAVOLAINEN, S
    SODERQVIST, A
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (03) : 229 - 234
  • [50] TISSUE PENETRATIONS AND EFFICACY OF CEFPODOXIME PROXETIL IN THE TREATMENT OF ODONTOGENIC INFECTIONS
    ZOLFINO, I
    GABRIELE, M
    PANATTONI, E
    CAMPA, M
    FAVINI, P
    DANESI, R
    DELTACCA, M
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 87 - 89